CD16+ monocyte-derived macrophages activate resting T cells for HIV infection by producing CCR3 and CCR4 ligands

Journal of Immunology

Volumn 176, Issue 10, 2006, Pages 5760-5771

  Ancuta, Petronela ^a   Autissier, Patrick ^b   Wurcel, Alysse ^c   Zaman, Tauheed ^c   Stone, David ^c   Gabuzda, Dana ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c LEMUEL SHATTUCK HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CHEMOKINE; CHEMOKINE CCL22; CHEMOKINE CCL24; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; LIGAND; MONOCYTE CHEMOTACTIC PROTEIN 1; THYMUS AND ACTIVATION REGULATED CHEMOKINE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; MACROPHAGE; MONOCYTE DERIVED MACROPHAGE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; T LYMPHOCYTE ACTIVATION; VIRUS REPLICATION;

EID: 33646492298     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.10.5760     Document Type: Article

References (73)

1. + subpopulation. Immunol. Today 17: 424-428.
2. Grage-Griebenow, E., H. D. Flad, and M. Ernst. 2001. Heterogeneity of human peripheral blood monocyte subsets. J. Leukocyte Biol. 69: 11-20.
3. + monocytes. J. Exp. Med. 197: 1701-1707.
4. Schakel, K., R. Kannagi, B. Kniep, Y. Goto, C. Mitsuoka, J. Zwirner, A. Soruri, M. von Kietzell, and E. Rieber. 2002. 6-Sulfo LacNAc, a novel carbohydrate modification of PSGL-1, defines an inflammatory type of human dendritic cells. Immunity 17: 289-301.
5. ++ monocytes area major source of TNF. J. Immunol. 168: 3536-3542.
6. Allan, D. S., M. Colonna, L. L. Lanier, T. D. Churakova, J. S. Abrams, S. A. Ellis, A. J. McMichael, and V. M. Braud. 1999. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J. Exp. Med. 189: 1149-1156.
7. +) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting. J. Exp. Med. 196: 517-527.
8. Krutzik, S. R., B. Tan, H. Li, M. T. Ochoa, P. T. Liu, S. E. Sharfstein, T. G. Graeber, P. A. Sieling, Y. J. Liu, T. H. Rea, et al. 2005. TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat. Med. 11: 653-660.
9. Geissmann, F., S. Jung, and D. R. Littman. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71-82.
10. Weber, C., K. U. Belge, P. von Hundelshausen, G. Draude, B. Steppich, M. Mack, M. Frankenberger, K. S. Weber, and H. W. Ziegler-Heitbrock. 2000. Differential chemokine receptor expression and function in human monocyte subpopulations. J. Leukocyte Biol. 67: 699-704.
11. Foussat, A., L. Bouchet-Delbos, D. Berrebi, I. Durand-Gasselin, A. Coulomb-L'Hermine, R. Krzysiek, P. Galanaud, Y. Levy, and D. Emilie. 2001. Deregulation of the expression of the fractalkine/fractalkine receptor complex in HIV-1-infected patients. Blood 98: 678-1686.
12. Pereira, C. F., J. Middel, G. Jansen, J. Verhoef, and H. S. Nottet. 2001. Enhanced expression of fractalkine in HIV-1 associated dementia. J. Neuroimmunol. 115: 168-175.
13. Muehlhoefer, A., L. J. Saubermann, X. Gu, K. Luedtke-Heckenkamp, R. Xavier, R. S. Blumberg, D. K. Podolsky, R. P. MacDermott, and H. C. Reinecker. 2000. Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa. J. Immunol. 164: 3368-3376.
14. high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur. J. Immunol. 25: 3418-3424.
15. Amirayan-Chevillard, N., H. Tissot-Dupont, C. Capo, C. Brunet, F. Dignat-George, Y. Obadia, H. Gallais, and J. L. Mege. 2000. Impact of highly active anti-retroviral therapy (HAART) on cytokine production and monocyte subsets in HIV-infected patients. Clin. Exp. Immunol. 120: 107-112.
16. Pulliam, L., R. Gascon, M. Stubblebine, D. McGuire, and M. S. McGrath. 1997. Unique monocyte subset in patients with AIDS dementia. Lancet 349: 692-695.
17. Gartner, S. 2000. HIV infection and dementia. Science 287: 602-604.
18. Miller, L. S., K. Atabai, M. Nowakowski, A. Chan, M. H. Bluth, H. Minkoff, and H. G. Durkin. 2001. Increased expression of CD23 (Fcε receptor II) by peripheral blood monocytes of aids patients. AIDS Res. Hum. Retroviruses 17: 443-452.
19. Cohen, O. J., A. Kinter, and A. S. Fauci. 1997. Host factors and the pathogenesis of HIV-1 disease. Immunol. Rev. 159: 31-48.
20. Sonza, S., A. Maerz, N. Deacon, J. Meanger, J. Mills, and S. Crowe. 1996. Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J. Virol. 70: 3863-3869.
21. Triques, K., and M. Stevenson. 2004. Characterization of restrictions to human immunodeficiency virus type 1 infection of monocytes. J. Virol. 78: 5523-5527.
22. Crowe, S., T. Zhu, and W. A. Muller. 2003. The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection. J. Leukocyte Biol. 21: 21.
23. Pierson, T., J. McArthur, and R. F. Siliciano. 2000. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu. Rev. Immunol. 18: 665-708.
24. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61: 213-222.
25. + T cells. Nature 435: 108-114.
26. + T cells. Nature 417: 95-98.
27. + T cells. J. Exp. Med. 201: 2023-2033.
28. Bromley, S. K., W. R. Burack, K. G. Johnson, K. Somersalo, T. N. Sims, C. Sumen, M. M. Davis, A. S. Shaw, P. M. Allen, and M. L. Dustin. 2001. The immunological synapse. Annu. Rev. Immunol. 19: 375-396.
29. Lanzavecchia, A., and F. Sallusto. 2001. The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr. Opin. Immunol. 13: 291-298.
30. Pope, M., M. G. Betjes, N. Romani, H. Hirmand, P. U. Cameron, L. Hoffman, S. Gezelter, G. Schuler, and R. M. Steinman. 1994. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 78: 389-398.
31. Geijtenbeek, T. B., D. S. Kwon, R. Torensma, S. J. van Vliet, G. C. van Duijnhoven, J. Middel, I. L. Cornelissen, H. S. Nottet, V. N. KewalRamani, D. R. Littman, et al. 2000. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100: 587-597.
32. McDyer, J. F., M. Dybul, T. J. Goletz, A. L. Kinter, E. K. Thomas, J. A. Berzofsky, A. S. Fauci, and R. A. Seder. 1999. Differential effects of CD40 ligand/trimer stimulation on the ability of dendritic cells to replicate and transmit HIV infection: evidence for CC-chemokine-dependent and -independent mechanisms. J. Immunol. 162: 3711-3717.
33. Swingler, S., A. Mann, J. Jacque, B. Brichacek, V. G. Sasseville, K. Williams, A. A. Lackner, E. N. Janoff, R. Wang, D. Fisher, and M. Stevenson. 1999. HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat. Med. 5: 997-103.
34. Swingler, S., B. Brichacek, J. M. Jacque, C. Ulich, J. Zhou, and M. Stevenson. 2003. HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection. Nature 424: 213-219.
35. + monocytes exposed to HIV promote highly efficient viral replication upon differentiation into macrophages and interaction with T cells. Virology 344: 267-276.
36. + T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous β-chemokines and the viral inductive effects of other endogenous cytokines. Proc. Natl. Acad. Sci. USA 93: 14076-14081.
37. Yi, Y., F. Shaheen, and R. G. Collman. 2005. Preferential use of CXCR4 by R5X4 human immunodeficiency virus type 1 isolates for infection of primary lymphocytes. J. Virol. 79: 1480-1486.
38. Unutmaz, D., V. N. KewalRamani, S. Marmon, and D. R. Littman. 1999. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J. Exp. Med. 189: 1735-1746.
39. ++ cells derived in vitro from peripheral blood monocytes exhibit phenotypic and functional dendritic cell-like characteristics. Eur. J. Immunol. 30: 1872-1883.
40. Tang, H. L., and J. G. Cyster. 1999. Chemokine up-regulation and activated T cell attraction by maturing dendritic cells. Science 284: 819-822.
41. + T cells in the absence of exogenous antigen. J. Immunol. 173: 50-60.
42. Molon, B., G. Gri, M. Bettella, C. Gomez-Mouton, A. Lanzavecchia, A. C. Martinez, S. Manes, and A. Viola. 2005. T cell costimulation by chemokine receptors. Nat. Immunol. 6: 465-471.
43. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277: 2005-2007.
44. Luther, S. A., and J. G. Cyster. 2001. Chemokines as regulators of T cell differentiation. Nat. Immunol. 2: 102-107.
45. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 2000. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18: 593-620.
46. Biswas, P., B. Mantelli, H. Hasson, A. Vecchi, A. Saniabadi, A. Lazzarin, and A. Beretta. 2003. In vivo modulation of leukocyte trafficking receptor following therapeutic purging of myeloid cells: implications for treatment of HIV infection and other immune disorders. Clin. Immunol. 109: 355-358.
47. + T cells. J. Immunol. 155: 4111-4117.
48. Kornbluth, R. S., K. Kee, and D. D. Richman. 1998. CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive β-chemokines. Proc. Natl. Acad. Sci. USA 95: 5205-5210.
49. Watanabe, K., P. J. Jose, and S. M. Rankin. 2002. Eotaxin-2 generation is differentially regulated by lipopolysaccharide and IL-4 in monocytes and macrophages. J. Immunol. 168: 1911-1918.
50. Fantuzzi, L., I. Canini, F. Belardelli, and S. Gessani. 2001. HIV-1 gp120 stimulates the production of β-chemokines in human peripheral blood monocytes through a CD4-independent mechanism. J. Immunol. 166: 5381-5387.
51. Fantuzzi, L., F. Spadaro, G. Vallanti, I. Canini, C. Ramoni, E. Vicenzi, F. Belardelli, G. Poli, and S. Gessani. 2003. Endogenous CCL2 (monocyte chemotactic protein-1) modulates human immunodeficiency virus type-1 replication and affects cytoskeleton organization in human monocyte-derived macrophages. Blood 102: 2334-2337.
52. Fonteneau, J. F., M. Larsson, A. S. Beignon, K. McKenna, I. Dasilva, A. Amara, Y. J. Liu, J. D. Lifson, D. R. Littman, and N. Bhardwaj. 2004. Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J. Virol. 78: 5223-5232.
53. Fantuzzi, L., C. Purificato, K. Donato, F. Belardelli, and S. Gessani. 2004. Human immunodeficiency virus type 1 gp120 induces abnormal maturation and functional alterations of dendritic cells: a novel mechanism for AIDS pathogenesis. J. Virol. 78: 9763-9772.
54. Chomarat, P., J. Banchereau, J. Davoust, and A. K. Palucka. 2000. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat. Immunol. 1: 510-514.
55. + T cell activation. J. Immunol. 164: 5010-5014.
56. Marsland, B. J., P. Battig, M. Bauer, C. Ruedl, U. Lassing, R. R. Beerli, K. Dietmeier, L. Ivanova, T. Pfister, L. Vogt, et al. 2005. CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells. Immunity 22: 493-505.
57. + T cells: role of signal transduction. Proc. Natl. Acad. Sci. USA 95: 11880-11885.
58. Vicenzi, E., M. Alfano, S. Ghezzi, A. Gatti, F. Veglia, A. Lazzarin, S. Sozzani, A. Mantovani, and G. Poli. 2000. Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1α, and MCP-3, and enhancement by MCP-1. J. Leukocyte Biol. 68: 405-412.
59. Weiss, L., A. Si-Mohamed, P. Giral, P. Castiel, A. Ledur, C. Blondin, M. D. Kazatchkine, N. Haeffner-Cavaillon, J. Gilquin, and M. Laude. 1997. Plasma levels of monocyte chemoattractant protein-1 but not those of macrophage inhibitory protein-1α and RANTES correlate with virus load in human immunodeficiency virus infection. J. Infect. Dis. 176: 1621-1624.
60. Gonzalez, E., B. H. Rovin, L. Sen, G. Cooke, R. Dhanda, S. Mummidi, H. Kulkarni, M. J. Bamshad, V. Telles, S. A. Anderson, et al. 2002. HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc. Natl. Acad. Sci. USA 99: 13795-13800.
61. Smith, M. W., M. Carrington, C. Winkler, D. Lomb, M. Dean, G. Huttley, and S. J. O'Brien. 1997. CCR2 chemokine receptor and AIDS progression. Nat. Med. 3: 1052-1053.
62. Forssmann, U., M. Uguccioni, P. Loetscher, C. A. Dahinden, H. Langen, M. Thelen, and M. Baggiolini. 1997. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J. Exp. Med. 185: 2171-2176.
63. Cota, M., M. Mengozzi, E. Vicenzi, P. Panina-Bordignon, F. Sinigaglia, P. Transidico, S. Sozzani, A. Mantovani, and G. Poli. 2000. Selective inhibition of HIV replication in primary macrophages but not T lymphocytes by macrophage-derived chemokine. Proc. Natl. Acad. Sci. USA 97: 9162-9167.
64. Trautmann, A. 2005. Chemokines as immunotransmitters? Nat. Immunol. 6: 427-428.
65. Taub, D. D., S. M. Turcovski-Corrales, M. L. Key, D. L. Longo, and W. J. Murphy. 1996. Chemokines and T lymphocyte activation: I. β Chemokines costimulate human T lymphocyte activation in vitro. J. Immunol. 156: 2095-2103.
66. Bromley, S. K., D. A. Peterson, M. D. Gunn, and M. L. Dustin. 2000. Cutting edge: hierarchy of chemokine receptor and TCR signals regulating T cell migration and proliferation. J. Immunol. 165: 15-19.
67. + central memory T cells. J. Exp. Med. 200: 725-735.
68. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3: 23-35.
69. Clerici, M., and G. M. Shearer. 1994. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol. Today 15: 575-581.
70. Maggi, E., M. Mazzetti, A. Ravina, F. Annunziato, M. de Carli, M. P. Piccinni, R. Manetti, M. Carbonari, A. M. Pesce, and G. del Prete. 1994. Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science 265: 244-248.
71. + T cells. J. Leukocyte Biol. 72: 913-920.
72. + T cell proliferation in HIV-positive patients as a result of CD28 costimulation. Science 272: 1939-1943.
73. Berger, E. A., P. M. Murphy, and J. M. Farber. 1999. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17: 657-700.